-
-
-
-
-
-
-
Tiziana Life Sciences (TLSA) Announces Presentation of Anti-CD3 mAb Research for the Treatment of Alzheimer’s Disease
-
-
-
-
-
-
-
Tiziana Life Sciences (TLSA) Announces 29.3K Insider Buy by Executive Chairman
-
-
-
-
-
-
-
Tiziana Announces Submission of Amendment to Investigational New Drug Application to Advance Oral Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, in Patients with Crohn’s Disease
-
727 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

